MYST
Myst Therapeutics, Inc.
Mark For: MYST™ trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 88481183 |
| Mark Literal Elements | MYST |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK. SERVICE MARK |
| Register | PRINCIPAL |
| Current Location | TMO LAW OFFICE 121 - EXAMINING ATTORNEY ASSIGNED 2019-09-19 |
| Basis | 1(b) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | Yes |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Julia Spoor Gard |
| Attorney Docket Number | 79462-296520 |
| Law Office Assigned | N30 |
| Employee Name | RAJA, AMER YASIN |
Timeline
| 2019-06-20 | Application Filed |
| 2019-09-19 | Location: TMO LAW OFFICE 121 - EXAMINING ATTORNEY ASSIGNED |
| 2019-09-19 | Status: Live/Pending |
| 2019-09-19 | Transaction Date |
| 2020-03-18 | Status: Applicant's response to a non-final Office action has been entered. The application is being returned to the examining attorney |
Trademark Parties (Applicants & Owners)
| Party: |  Myst Therapeutics, Inc. |
| Address | 3422 Beethoven Street Los Angeles, CALIFORNIA UNITED STATES 90066 |
| Legal Entity Type | Corporation |
| Legal Entity State | DELAWARE |
Documents
 Drawing | IMAGE/JPEG | 2019-06-20 |
 TEAS RF New Application | APPLICATION/XML,IMAGE/JPEG | 2019-06-20 |
| Offc Action Outgoing | MULTI | 2019-09-19 |
| Response to Office Action | MULTI | 2020-03-18 |
| Amendment and Mail Process Complete | APPLICATION/XML,IMAGE/JPEG | 2020-03-19 |
Attorney of Record
Good, Services, and Codes
IC 005. US 006 018 044 046 051 052. G & S: pharmaceutical products for the prevention and treatment of cancer; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer and tumors; pharmaceutical preparation for T Cell therapy; biological preparations for the treatment of cancer and tumors
IC 036. US 100 101 102. G & S: financial administration of patient reimbursement programs; financial administration of medication reimbursement programs and services
IC 040. US 100 103 106. G & S: custom manufacturing of biological tissue, blood, and cells; custom manufacturing of pharmaceutical preparations for immunotherapy
IC 045. US 100 101. G & S: providing patient advocate services in the field of the treatment of diseases and disorders
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 36 |
| U.S. Codes: | 100,101,102 |
| International Codes: | 40 |
| U.S. Codes: | 100,103,106 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| International Codes: | 45 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0051 | pharmaceutical products for the prevention and treatment of cancer; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer and tumors; pharmaceutical preparation for T Cell therapy; biological preparations for the treatment of cancer and tumors |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-03-18 | 88889 |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-03-18 | |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-03-18 | 88889 |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-09-19 | 6325 |
| NON-FINAL ACTION WRITTEN | 2019-09-19 | 92842 |
| NON-FINAL ACTION E-MAILED | 2019-09-19 | 6325 |
| ASSIGNED TO EXAMINER | 2019-09-12 | 92842 |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-06-30 | |
| NEW APPLICATION ENTERED IN TRAM | 2019-06-24 |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 